comparemela.com

Latest Breaking News On - Sherrington robin - Page 1 : comparemela.com

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Canada
Steven-gannon
Sherrington-robin
Xenon-pharmaceuticals-price-performance
Cantor-fitzgerald
Ikarian-capital
Xenon-pharmaceuticals-inc
Nasdaq
Xenon-pharmaceuticals
Needham-company

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
Wellington
New-zealand-general
New-zealand
Steven-gannon
Sherrington-robin
Capital-international-investors
News-ratings-for-xenon-pharmaceuticals-daily
Wellington-management-group
Citigroup
Royal-bank
Avoro-capital-advisors

Westfield Capital Management Co. LP Invests $10.94 Million in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Westfield Capital Management Co. LP acquired a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 237,495 shares of the biopharmaceutical company’s stock, valued at approximately $10,939,000. Westfield Capital Management Co. […]

Switzerland
Canada
Alps
Switzerland-general
Texas
United-states
Arizona
Swiss
Steven-gannon
Sherrington-robin
Needham-company
Westfield-capital-management-co

Westfield Capital Management Co. LP Buys Shares of 237,495 Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Westfield Capital Management Co. LP bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 237,495 shares of the biopharmaceutical company’s stock, valued at approximately $10,939,000. A number of […]

Canada
Wellington
New-zealand-general
New-zealand
Sherrington-robin
Steven-gannon
First-turn-management
Citigroup
Timessquare-capital-management
Westfield-capital-management-co
Needham-company
Xenon-pharmaceuticals-inc

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Buy" by Brokerages

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the stock […]

China
Canada
Steven-gannon
Sherrington-robin
Xenon-pharmaceuticals-stock-performance
Cantor-fitzgerald
Financial-services-group-inc
Nasdaq
Capital-partners
News-ratings-for-xenon-pharmaceuticals-daily
Analyst-recommendations-for-xenon-pharmaceuticals
Citigroup

vimarsana © 2020. All Rights Reserved.